Filing Details
- Accession Number:
- 0001493152-17-006346
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-08 18:30:13
- Reporting Period:
- 2017-06-07
- Filing Date:
- 2017-06-08
- Accepted Time:
- 2017-06-08 18:30:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
737207 | Marina Biotech Inc. | MRNA | Pharmaceutical Preparations (2834) | 112658569 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1587074 | Vuong Trieu | C/O Marina Biotech, Inc. 17870 Castleton Street, Suite 250 City Of Industry CA 91748 | Chairman Of The Board | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-06-08 | 20,000 | $0.39 | 11,117,141 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-06-07 | 2,500 | $0.38 | 11,097,141 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 862,068 | Indirect | See Footnote |
Common Stock | 23,123,558 | Indirect | See Footnote |
Common Stock | 5,255,354 | Indirect | See Footnote |
Common Stock | 1,928,571 | Direct |
Footnotes
- Represents shares held by Lipomedics Inc., of which entity the reporting person serves as Chairman of the Board and Chief Operating Officer.
- Represents shares held by Autotelic LLC, of which entity the reporting person serves as Chief Executive Officer.
- Represents shares held by Autotelic Inc., of which entity the reporting person serves as Chairman of the Board.
- Represents shares issuable to the reporting person upon the conversion of a promissory note held by the reporting person (at an assumed conversion price of $0.28).